SPX3,585.62-54.85 -1.51%
DIA287.30-4.91 -1.68%
IXIC10,575.62-161.89 -1.51%

SVB Leerink Maintains Outperform on Pharvaris, Lowers Price Target to $20

SVB Leerink analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $25 to $20.

Benzinga · 09/14/2022 04:36
SVB Leerink analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $25 to $20.